Literature DB >> 27681782

The cancer vaccine resurgence.

Asher Mullard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27681782     DOI： 10.1038/nrd.2016.201

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  19 in total

Review 1.  Delivery technologies for cancer immunotherapy.

Authors:  Rachel S Riley; Carl H June; Robert Langer; Michael J Mitchell
Journal:  Nat Rev Drug Discov       Date:  2019-03       Impact factor: 84.694

Review 2.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

Review 3.  Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.

Authors:  Mariona Cabo; Rienk Offringa; Laurence Zitvogel; Guido Kroemer; Aura Muntasell; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-08-30       Impact factor: 8.110

4.  Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.

Authors:  Kaïdre Bendjama; Eric Quemeneur
Journal:  Hum Vaccin Immunother       Date:  2017-08-28       Impact factor: 3.452

Review 5.  Immune targets and neoantigens for cancer immunotherapy and precision medicine.

Authors:  Rong-Fu Wang; Helen Y Wang
Journal:  Cell Res       Date:  2016-12-27       Impact factor: 25.617

6.  Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next-Generation Sequencing Data.

Authors:  Begoña Alburquerque-González; María Dolores López-Abellán; Ginés Luengo-Gil; Silvia Montoro-García; Pablo Conesa-Zamora
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Drug development in the era of precision medicine.

Authors:  Sarah A Dugger; Adam Platt; David B Goldstein
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

Review 8.  Targeting mRNA processing as an anticancer strategy.

Authors:  Joana Desterro; Pedro Bak-Gordon; Maria Carmo-Fonseca
Journal:  Nat Rev Drug Discov       Date:  2019-09-25       Impact factor: 84.694

9.  Synthetic Immunobiotics: A Future Success Story in Small Molecule-Based Immunotherapy?

Authors:  Mary J Sabulski Feigman; Marcos M Pires
Journal:  ACS Infect Dis       Date:  2018-02-16       Impact factor: 5.578

Review 10.  Nanotechnology synergized immunoengineering for cancer.

Authors:  Deepak S Chauhan; Anupam Dhasmana; Partha Laskar; Rajendra Prasad; Nishant K Jain; Rohit Srivastava; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Eur J Pharm Biopharm       Date:  2021-03-24       Impact factor: 5.589
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.